Mytesi oral tabs

Ended Awarded Last action

Contract number
36C26024F0430
Awardee
Awarding agency
Obligated
$3,378

Award facts

Contract value 100% obligated
$3,378.02 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
San Francisco, CA 94104, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · Mytesi oral tabs - change PO from a c# to an a# $0
Original award $3,378

About this award

This is a delivery order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 20 to Napo Pharmaceuticals Inc., a subsidiary of Jaguar Health Inc. The contract is for the delivery of Mytesi (crofelemer), a 125mg oral tablet used to treat non-infectious diarrhea in adult HIV/AIDS patients receiving antiretroviral therapy. The contract has a ceiling value of $3,378.02 and is a firm fixed-price delivery order. It does not have a set-aside designation, indicating Napo Pharmaceuticals competed in the open market. The contract is issued under Napo Pharmaceuticals' Federal Supply Schedule (FSS) contract, which is a multiple-award Indefinite Delivery Vehicle (IDV) with a total value of $1,151,660. This allows VA healthcare facilities to efficiently order the specialized medication through a pre-established schedule. The contract supports the VA's commitment to providing critical pharmaceutical products for veteran patients.

Quick answers

Who was awarded contract 36C26024F0430?

36C26024F0430 was awarded to Napo Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on June 3, 2024.

How much is contract 36C26024F0430 worth?

The government has obligated $3,378 on 36C26024F0430.

Is contract 36C26024F0430 an order under another contract?

Yes. 36C26024F0430 is a delivery order under 36F79723D0158, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26024F0430 competed?

The extent of competition for 36C26024F0430 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award